UNITED STATES: FDA clears Iqos for marketing as "risk reduction tool"

UNITED STATES: FDA clears Iqos for marketing as "risk reduction tool"

Unsurprisingly, La Food and Drug Administration (FDA) in charge of health protection in the United States has just authorized Philip Morris to indicate that his IQOS (Heated tobacco) is a real risk reduction tool against smoking.


IQOS, A “TOOL TO REDUCE TOBACCO RISKS”?


 » FDA (Food and Drug Administration) Authorizes Marketing of IQOS as a Modified Risk Tobacco Product ", Announcement Philip Morris in a press release published a few days ago. The tobacco company had been waiting for such a decision from the US administration for several years.

In 2016, the company had submitted to the American administration a body of work supporting the idea that the use of Iqos entails reduced health risks compared to the use of conventional cigarettes.

Philip Morris (PMI) is authorized since April 2019 to sell the Iqos in the United States. But the world's leading tobacco manufacturer (16% of the market) was waiting to be able to communicate on its product in a different way from that imposed for cigarettes. It is now done in one of the first markets in the world. The company may well indicate in its communication that the tobacco present in its IQOS is not burned but heated.

« FDA concluded that available scientific evidence demonstrates that Iqos can be expected to benefit the health of the population as a whole, taking into account both tobacco users and individuals who are not currently consuming it ", Indicates the cigarettier.

Com Inside Bottom
Com Inside Bottom
Com Inside Bottom
Com Inside Bottom

About the Author

Editor-in-chief of Vapoteurs.net, the reference site for vaping news. Engaged in the world of vaping since 2014, I work every day to ensure that all vapers and smokers are informed.